BANK OF AMERICA CORP /DE/ - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$7,142,798
-14.6%
762,305
+123.6%
0.00%0.0%
Q2 2023$8,362,325
-41.1%
340,902
-44.1%
0.00%0.0%
Q1 2023$14,188,069
+9.9%
609,715
+19.6%
0.00%0.0%
Q4 2022$12,904,378
+53.5%
509,853
+16.9%
0.00%0.0%
Q3 2022$8,408,000
+67.6%
436,090
+121.4%
0.00%0.0%
Q2 2022$5,016,000
-61.1%
196,944
-60.7%
0.00%0.0%
Q1 2022$12,890,000
+1.3%
501,179
+64.9%
0.00%0.0%
Q4 2021$12,725,000
+47.0%
303,905
+52.8%
0.00%0.0%
Q3 2021$8,656,000
-21.7%
198,883
-14.9%
0.00%0.0%
Q2 2021$11,048,000
+20.5%
233,674
+30.7%
0.00%0.0%
Q1 2021$9,166,000
+647.6%
178,786
+290.5%
0.00%
Q4 2020$1,226,000
+42.9%
45,788
+83.2%
0.00%
Q3 2020$858,000
-54.8%
24,987
-46.1%
0.00%
Q2 2020$1,899,000
+3118.6%
46,356
+2587.3%
0.00%
Q1 2020$59,000
+321.4%
1,725
+54.6%
0.00%
Q4 2019$14,0001,1160.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders